You are here
ZYMERA, INC.
UEI: N/A
# of Employees: 5
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of a Protease Activity Assay for Melanoma Prognostics
Amount: $219,564.00DESCRIPTION (provided by applicant): The objective of this Phase I project is the development of novel assays for gelatinase - i.e., matrix metalloprotease 2 and 9 - activity using a proprietary enhan ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
IGF::OT::IGF OTHER FUNCTIONS RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH) SBIR PHASE II TOPIC NO. 266 PROJECT ENTITLED: HOMOGENEOUS NANO PARTICLE- BASED ASSAYS FOR PROTEASE DETECTION
Amount: $1,103,426.00The objectives of the Phase II project are to further develop a new protease detection technology platform with versatile application capabilities (in vitro and in vivo) including cancer applications ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
SBIR Phase II: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging
Amount: $600,296.00This Small Business Innovation Research (SBIR) Phase II project will demonstrate the production of robust, versatile probes based on Bioluminescence Resonance Energy Transfer to Quantum Dots (BRET-Qdo ...
SBIRPhase II2010National Science Foundation -
STTR Phase I: Non-Toxic Nanoparticles for BRET-Based Molecular Imaging
Amount: $150,000.00This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer (STTR) Phase I project will result in the demonstration of no ...
STTRPhase I2009National Science Foundation -
SBIR Phase I: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging
Amount: $100,000.00This Small Business Innovation Research (SBIR) Phase I project will demonstrate the detection of an established target in cancer diagnosis and treatment using new targeted Bioluminescence Resonance En ...
SBIRPhase I2009National Science Foundation -
SBIR TOPIC 266: HOMOGENOUS NANOPARTICLE-BASED ASSAYS FOR PROTEASE DETECTION
Amount: $199,948.00SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
SBIR Phase I: Bioluminescence Resonance Energy Transfer Assays for Clinical Chemistry
Amount: $99,993.00This Small Business Innovation Research (SBIR) Phase I research project aims to develop a point-of-care assay for creatine kinase, an important toxicity biomarker, to screen for adverse drug reactions ...
SBIRPhase I2007National Science Foundation